Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALGeneric

TESTOSTERONE

TESTOSTERONE

Standard Dose
1.62% (20.25MG/1.25GM ACTUATION)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TESTOSTERONE is listed in Drugs@FDA under application 213922 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION) Sponsor ALEMBIC Submission history Latest submission status date: 2021-03-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview TESTOSTERONE is listed in Drugs@FDA under application 213922 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION) Sponsor ALEMBIC Submission history Latest submission status date: 2021-03-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.